Bone disease in Myeloma: The claws of CRAB

Rafael Fonseca; Tania Jain

doi:10.1158/1078-0432.CCR-15-2981

Bone disease in Myeloma: The claws of CRAB

Rafael Fonseca, Tania Jain

Research output: Contribution to journal › Article › peer-review

Abstract

A dynamic approach to use bisphosphonates according to biomarkers of bone metabolism is presented in the Z-MARK study by Raje and colleagues. This is a major step forward toward a rational approach to bisphosphonate usage.

Original language	English (US)
Pages (from-to)	1301-1303
Number of pages	3
Journal	Clinical Cancer Research
Volume	22
Issue number	6
DOIs	https://doi.org/10.1158/1078-0432.CCR-15-2981
State	Published - Mar 15 2016
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-15-2981

Fingerprint Dive into the research topics of 'Bone disease in Myeloma: The claws of CRAB'. Together they form a unique fingerprint.

Cite this

@article{f419d65a490347d283bb00e693886d69,

title = "Bone disease in Myeloma: The claws of CRAB",

abstract = "A dynamic approach to use bisphosphonates according to biomarkers of bone metabolism is presented in the Z-MARK study by Raje and colleagues. This is a major step forward toward a rational approach to bisphosphonate usage.",

author = "Rafael Fonseca and Tania Jain",

year = "2016",

month = mar,

day = "15",

doi = "10.1158/1078-0432.CCR-15-2981",

language = "English (US)",

volume = "22",

pages = "1301--1303",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "6",

}

TY - JOUR

T1 - Bone disease in Myeloma

T2 - The claws of CRAB

AU - Fonseca, Rafael

AU - Jain, Tania

PY - 2016/3/15

Y1 - 2016/3/15

N2 - A dynamic approach to use bisphosphonates according to biomarkers of bone metabolism is presented in the Z-MARK study by Raje and colleagues. This is a major step forward toward a rational approach to bisphosphonate usage.

AB - A dynamic approach to use bisphosphonates according to biomarkers of bone metabolism is presented in the Z-MARK study by Raje and colleagues. This is a major step forward toward a rational approach to bisphosphonate usage.

UR - http://www.scopus.com/inward/record.url?scp=84962217159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962217159&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-15-2981

DO - 10.1158/1078-0432.CCR-15-2981

M3 - Article

C2 - 26792259

AN - SCOPUS:84962217159

VL - 22

SP - 1301

EP - 1303

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 6

ER -